where viable bacilli, though in a resting phase, may remain for long periods. It is of interest to know which drugs or combination of drugs have activity against such a resting population. From our own results it is obvious that a powerful combination of bactericidal drugs, such as isoniazid and pyrazinamide, can kill bacilli even when they are in a non-dividing state. It is equally clear from the work of McCune & Tompsett (1956) with p-aminosalicylic acid and of Hart & Rees (1960) with macrocyclon, that these bacteriostatic drugs have little or no effect against chronic infection in mice. Yet both these drugs, in particular macrocyclon, have considerable activity against an acute infection in micewhere the bacterial population is a freely multiplying one. The contrast between the effectiveness of macrocyclon and p-aminosalicylic acid in vivo against an acute infection, and their ineffectiveness against a chronic infection, is almost certainly a reflection of similar contrasts between the action in vitro of other bacteriostatic drugs on multiplying and nonmultiplying bacilli (Singh & Mitchison 1955 , Hobby & Lenert 1957 . McCune et al. (1956) also found little or no evidence of drug resistance during the treatment of chronic murine infections. This is probably because resistant variants could not grow out from a predominantly resting population of bacilli. The dual counting technique, including the counting of total numbers of stained bacilli in the lungs, shows that even when a very high proportion of the bacilli are killed by chemotherapy they can remain in a stainable form in situ for many weeks. From other exoerimental work this finding is not unexpected since it is known that dead pathogenic mycobacteria injected into animals remain in situ in a stainable state for very long periods. In man, in contrast with mice, the pulmonary lesions remain open and killed bacilli are readily shed into the bronchi. Also in man, stainable but culture-negative bacilli are not uncommonly found, particularly after chemotherapy, in the closed 'round lesions' in the lungs and other isolated sites in the body. It has been suggested that these organisms are not really dead but only modified by chemotherapy and unable to grow in the usual culture media. Our experimental findings are against this hypothesis because they clearly show that acid-fastness can persist in vivo long after the organism is dead. This work has been carried out in collaboration with my colleague Dr P D'Arcy Hart. Anonymous Mycobacteria as a Cause of Phthisis by J Marks MD MRCP (Cardiff) The diagnosis of phthisis by bacteriological methods dates from 1882 but it was not until some decades later that the cultivation of tubercle bacilli became widely practised. From that time, reports began to appear in the literature of unusual mycobacteria isolated from apparently typical cases of tuberculosis. Although most of the early observations were limited to one or two cases, several authors recognized and discussed fully the significance of these mycobacteria (e.g. Beaven & Bayne-Jones 1931); but little general interest was aroused in either the organisms or the disease with which they were associated. That situation has now changed. The reports have multiplied and the subject has become familiar to all interested in chest disease. Two factors especially have been responsible for this development. First, the introduction of chemotherapy for tuberculosis not only led to a demand for many more cultures for the purpose of sensitivity tests, but also obliged the bacteriologist to consider carefully the characteristics of individual strains. Consequently, some organisms which formerly would have been accepted as tubercle bacilli are now recognized as being distinct. Secondly, the recession of tuberculosis in many countries has thrown these anomalous infections into greater prominence. It is possible also that, in addition to better recognition, there has been a true increase in incidence in recent years.
The mycobacteria under consideration have no accepted name. It is convenient therefore to use the provisional name 'anonymous mycobacteria' suggested by Runyon (1959) . The disease caused by anonymous mycobacteria also has no name and for this I have suggested elsewhere the term 'mycobacterial pseudotuberculosis' (Marks & Trollope 1960) .
,Etiology
The incidence of mycobacterial pseudotuberculosis appears to vary considerably in different parts of the world but interest in the disease and facilities for its recognition are so unevenly distributed that it will be some time before an accurate picture can be obtained. It is already clear, however, that different varieties of anonymous mycobacteria predominate in different areas. All reports agree that men are much more commonly affected than women and that most infections occur in middle age or later. Not infrequently the disease is found in association with pneumoconiosis or aspiration pneumonia and it seems likely that these lung affections are local predisposing factors. In some instances there appears to be a general predisposition to mycobacterial infection as a consequence of malnutrition or, as in two of my own cases, steroid therapy. Although an accurate estimate is not yet possible, I would place the incidence of mycobacterial pseudotuberculosis in Great Britain at about 200 new cases a year.
Pseudotuberculosis does not appear to be infectious to contacts. Infection must therefore arise from human carriers, from animals or from free-living organisms. A survey in a rural area of Georgia demonstrated mycobacteria in the saliva or sputum of 16 out of 122 healthy people (Edwards & Palmer 1959) . However, these mycobacteria may have been free-living organisms recently inhaled or ingested in an area where they are prevalent. In contrast, Dr Erin and I failed to isolate anonymous mycobacteria from samples of sputum or saliva submitted by about 4,000 members of the general public in an area of South Wales. Little is known of infection, carriage or excretion by animals. It is of interest, however, that cows may become sensitized to mycobacterial antigens in circumstances that make tuberculosis unlikely; also that a number of anonymous strains cannot be distinguished from avian-type tubercle bacilli which have lost virulence. Nevertheless, the origin of most anonymous mycobacteria is probably the great reservoir of freeliving mycobacteria. These are known to include species with a certain degree of pathogenicity such as Mycobacterium balnei.
Classification
On the whole, pulmonary and non-pulmonary forms of pseudotuberculosis are distinct. Extension of lung infection to give empyema or metastatic lesions does occur but is uncommon. Non-pulmonary disease mostly takes the form of cervical adenitis or skin lesions. In the case of cervical adenitis at least, a special type of organism is frequently responsible which is rarely found in lung infections.
Morbid Anatomy and Bacteriology
The macroscopic and histological appearances of lung lesions cannot be distinguished with certainty from those of tuberculosis. In abscesses, as noted by Cobbett (1918) , the leucocytes maintain their structure much better in pseudotuberculosis than in tuberculosis.
Bacteriological diagnosis is made by the use of a number of cultural and biochemical tests (Marks & Trollope 1960) ; animal inoculation is only required to ensure that virulent tubercle bacilli are not being masked. Repeated isolations are essential for diagnosis as the anonymous mycobacteria cannot always be distinguished from the saprophytic or commensal organisms which occasionally get into specimens by accident. Runyon (1959) showed that the anonymous mycobacteria can be divided into three main groups on the basis of pigmentation. These are as follows: I Photochromogens, which are cream or buff when growing in the dark but which develop a yellow or orange colour rapidly when grown after exposure to light.
II Scotochromogens, which are yellow, orange or reddish from the onset of growth whether in the light or dark.
III Nonphotochromogens, which are cream or buff both in the light and dark although a number of strains produce other pigment on prolonged incubation.
Most Group I strains are isolated in circumstances suggesting pathogenic activity. In contrast, Group It strains are usually casual intruders except for a sub-group with distinct properties, which are especially associated with cervical adenitis. Group III is also mixed. The members which grow slowly often prove to be pathogens and those that grow fast are usually strains with-10 out significance. Nevertheless, fast growers cannot be dismissed without investigation as they are undoubtedly responsible for some cases of pseudotuberculosis.
Symptoms and Signs
Pseudotuberculosis produces symptoms and signs similar to those of the less acute forms of tuberculosis. As with tuberculosis, symptomless lesions occur which are disclosed by radiography and are identified by bacteriological examination. The infection is sometimes overlooked when superimposed on chronic lung disease, deterioration of the patient's condition being then attributed to the underlying disease. Hxmoptysis and cavitation are somewhat more frequent in pseudotuberculosis than in tuberculosis and the lesions are more often unilateral and localized. However, the radiological appearances are not certainly distinguishable in the two infections.
Diagnosis
The distinction from tuberculosis is made on bacteriological grounds. The organism has to be distinguished from a tubercle bacillus and must be isolated repeatedly from the lesion or morbid materials (usually sputum). Before a diagnosis of pseudotuberculosis is made it is advisable to exclude the possibility that tubercle bacilli are being masked by inoculating one guinea-pig with a primary culture and another directly with morbid material, suitably decontaminated. If additional evidence is required, comparative skin tests may be made with tuberculin and protein prepared from the suspected pathogen.
Treatment andPrognosis
The severity of pseudotuberculosis varies considerably. Some patients recover spontaneously, but on the whole the prognosis is worse than in tuberculosis. The difficulty is that anonymous mycobacteria as a group are not very susceptible to the drugs developed for the chemotherapy of tuberculosis. It is not possible at present to offer much general guidance on chemotherapy. All the strains we have tested at Cardiff have been resistant in vitro to P.A.S. and pyrazinamide, but susceptibility to other drugs varied in different cases. The nonphotochromogens are the least susceptible group. It is not yet clear how reliable in vitro tests are as a guide to chemotherapy.
Excision of the lesion gives good results when it is practicable. The outlook is much less favourable with medical treatment. A study recently made by the Pneumoconiosis Research Unit has shown that this is particularly the case when the infection complicates pneumoconiosis (Kamat et al. 1961) .
As the risk to contacts appears to be negligible, there is no need to isolate patients with pseudotuberculosis. They should not however be nursed in contact with infectious tuberculosis since instances of superinfection with tubercle bacilli have been reported (Lewis et al. 1960) , and their resistance to mycobacteria is almost certainly low.
General Remarks
Relatively little is known about resistance to infection by anonymous mycobacteria but it probably operates in the same way as resistance to infection by tubercle bacilli. If this is true, one might expect innate immunity to be distributed similarly in the two cases and predict that as tuberculosis is eradicated, pseudotuberculosis will become more common, for some of the people who would otherwise have fallen victim to the former will do so to the latter. Studies in progress do indeed suggest that an increase is now occurring in Britain. Fortunately, the low virulence of the anonymous mycobacteria will not allow the incidence of pseudotuberculosis to reach a level anywhere near that of tuberculosis in the recent past.
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